Join us in-person or online for this CME symposium held during CHEST 2026
Rethinking Treatment Frequency in Severe Asthma:
A Case-Based Discussion of Emerging Evidence and Clinical Implications
Lunch will be served for in-person attendees.
Sunday, October 18, 2026
12-12:15 p.m. (CDT): Check in and Lunch
12:15-1:15 p.m. (CDT): Educational Program
Phoenix Convention Center
North Building Room #132
100 N 3rd St
Phoenix, AZ 85004
Add event to calendar
Severe asthma is associated with substantial morbidity, frequent exacerbations, and a high treatment burden despite available therapies. A significant proportion of patients exhibit Type 2 inflammation, including eosinophilic phenotypes, for which targeted biologic therapies have meaningfully improved disease control and reduced exacerbations. Recent therapeutic advances represent an important evolution in severe asthma management by introducing extended dosing intervals that have the potential to reduce treatment burden, support long-term adherence, and enhance sustained disease control in appropriately selected patients.
In this CME symposium, an expert panel of pulmonologists and allergists will discuss barriers to care, multidisciplinary collaboration, and the evolving treatment landscape in severe asthma. Throughout this case-based discussion, panelists will explore common challenges in severe asthma treatment, such as treatment escalation, shared decision-making, long-term disease control, and the impact of comorbidities and access barriers on outcomes.
Target Audience:
Pulmonologists, allergists, nurse practitioners and physician assistants who treat patients with severe asthma.
Program Faculty:
Flavia Cecilia Lega Hoyte, MD
Professor of Medicine
Division of Allergy & Clinical Immunology
Director, Allergy & Clinical Immunology Fellowship
National Jewish Health
Denver, CO
Eileen Wang, MD, MPH
Associate Professor of Medicine
Division of Allergy & Immunology Clinical Services
National Jewish Health
Denver, CO
Michael E. Wechser, MD, MMSc
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Director, The Cohen Family Asthma Institute
Edelstein Family Chair in Adult Pulmonary Medicine
National Jewish Health
Denver, CO
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@NJHealth.org.
Support:
This educational activity is supported by an independent medical education grant from GSK.
Registration Information:
If interested in attending, please register below. This CME symposium is complimentary for both in-person and livestream attendees.
In-Person:
- In-person attendees must be registered as part of the CHEST 2026 Conference to attend this event.
- In-person attendees may begin arriving at 12pm for check-in and lunch.
- Please arrive early, as seating and food may be limited.
Online:
- Online attendees do not need to be registered as part of the CHEST 2026 Conference to attend this online event.
- Online attendees will receive the link to view the live symposium via email the week before the event.
Add event to calendar